Skip to Main Content Menu Search Site

Beating Back the Coronavirus: FDA-Approved Drug Repurposing Pipeline

Previous Next

With the goal of rapidly repurposing FDA-approved drugs to treat COVID-19, the Wyss Institute is collaborating with the Frieman Lab at the University of Maryland Medical School and the tenOever Lab at the Icahn School of Medicine at Mount Sinai to establish a multidisciplinary pipeline that can rapidly predict, test, and validate potential treatments.

Credit: Wyss Institute at Harvard University

Close menu